Harbor Capital Advisors Inc. Buys 363,391 Shares of DocGo Inc. (NASDAQ:DCGO)

Harbor Capital Advisors Inc. boosted its stake in shares of DocGo Inc. (NASDAQ:DCGO) by 37.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,331,928 shares of the company’s stock after purchasing an additional 363,391 shares during the quarter. Harbor Capital Advisors Inc.’s holdings in DocGo were worth $5,647,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of DCGO. Bank of New York Mellon Corp grew its holdings in shares of DocGo by 40.7% during the 2nd quarter. Bank of New York Mellon Corp now owns 343,761 shares of the company’s stock worth $1,062,000 after purchasing an additional 99,359 shares in the last quarter. Rhumbline Advisers lifted its position in DocGo by 33.4% in the second quarter. Rhumbline Advisers now owns 146,188 shares of the company’s stock worth $452,000 after purchasing an additional 36,613 shares during the period. Victory Capital Management Inc. increased its holdings in DocGo by 124.0% in the 2nd quarter. Victory Capital Management Inc. now owns 25,635 shares of the company’s stock valued at $79,000 after buying an additional 14,191 shares during the period. XTX Topco Ltd acquired a new position in shares of DocGo in the 2nd quarter valued at $211,000. Finally, Marshall Wace LLP lifted its holdings in shares of DocGo by 212.4% during the 2nd quarter. Marshall Wace LLP now owns 505,514 shares of the company’s stock worth $1,562,000 after acquiring an additional 343,692 shares during the period. 56.44% of the stock is owned by institutional investors.

DocGo Stock Performance

Shares of NASDAQ DCGO opened at $4.08 on Friday. DocGo Inc. has a 52-week low of $2.75 and a 52-week high of $4.86. The business has a fifty day moving average of $4.17 and a two-hundred day moving average of $3.64. The stock has a market cap of $416.37 million, a PE ratio of 14.57, a PEG ratio of 3.94 and a beta of 0.97.

Analysts Set New Price Targets

Separately, Cantor Fitzgerald reissued an “overweight” rating and issued a $5.00 target price on shares of DocGo in a research note on Friday, September 20th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $6.10.

Insider Buying and Selling

In related news, General Counsel Ely D. Tendler sold 23,088 shares of the firm’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $4.44, for a total transaction of $102,510.72. Following the completion of the sale, the general counsel now directly owns 175,645 shares of the company’s stock, valued at $779,863.80. This trade represents a 11.62 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 2.70% of the stock is currently owned by corporate insiders.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.